MIT CAACB Risk Assessment Case Study: Assessing Virus Cross-Contamination Risk between Two Simultaneous Processes in an Open Biomanufacturing Facility.

Autor: Koenigsberg AL; Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA., Fowler V; Oxford Nanopore Technologies, Oxford, United Kingdom., Domike R; Light Pharma, Cambridge, MA.; Manufacturing Engineering at Brigham Young University, Provo, UT., Brussel A; PathoQuest, Paris, France., Barone PW; Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA., Keumurian FJ; Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA., Leung J; Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA., Wiebe ME; Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA., Brewer MT; ThermoFisher, Waltham, MA., Chan S; Gritstone, Emeryville, CA., Dumey N; Sanofi, Marcy L'Étoile, France., Fournillier A; Sanofi, Marcy L'Étoile, France., Goodnight M; AstraZeneca, Gaithersburg, MD., Kindermann J; Takeda, Vienna, Austria., Leavy R; Amgen, Thousand Oaks, CA., Lee B; Genentech, South San Francisco, CA., Minning S; Boehringer Ingelheim, Biberach, Germany., Murphy M; Eli Lilly, Dublin, Ireland., Myers E; Pfizer, Andover, MA., Nahabedian A; Pfizer, Andover, MA., Nanda K; Biogen, Durham, NC., Parriott S; BioMarin, San Rafael, CA., Raju GK; Light Pharma, Cambridge, MA., Scallan C; Gritstone, Emeryville, CA., Schoch S; CSL Behring, Marburg, Germany., Shiminsky J; BMS, Devens, MA., Shum B; Genentech, South San Francisco, CA., Teitz S; Asahi Kasei, Cologne, Germany; and., Westrek B; Merck & Co. Inc., Kenilworth, NJ., Springs SL; Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA; ssprings@mit.edu.

Publikováno v: PDA journal of pharmaceutical science and technology [PDA J Pharm Sci Technol] 2023 Mar-Apr; Vol. 77 (2), pp. 115-132. Date of Electronic Publication: 2022 Oct 14.

Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques.

Autor: Lorin C; GlaxoSmithKline Vaccines, Rixensart, Belgium., Segal L, Mols J, Morelle D, Bourguignon P, Rovira O, Mettens P, Silvano J, Dumey N, Le Goff F, Koutsoukos M, Voss G, Tangy F

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2012 Dec; Vol. 385 (12), pp. 1211-25. Date of Electronic Publication: 2012 Sep 16.

Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples.

Autor: Cheval J; Institut Pasteur, Genotyping of Pathogens and Public Health Platform, 28 Rue du Docteur Roux, F-75015 Paris, France., Sauvage V, Frangeul L, Dacheux L, Guigon G, Dumey N, Pariente K, Rousseaux C, Dorange F, Berthet N, Brisse S, Moszer I, Bourhy H, Manuguerra CJ, Lecuit M, Burguiere A, Caro V, Eloit M

Publikováno v: Journal of clinical microbiology [J Clin Microbiol] 2011 Sep; Vol. 49 (9), pp. 3268-75. Date of Electronic Publication: 2011 Jun 29.

Kinetic analysis of HIV-1 early replicative steps in a coculture system.

Autor: Barbosa P; Département SIDA et Rétrovirus, Institut Pasteur, Paris, France., Charneau P, Dumey N, Clavel F

Publikováno v: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 1994 Jan; Vol. 10 (1), pp. 53-9.

Investigation of viral etiology in potentially malignant disorders and oral squamous cell carcinomas in non-smoking, non-drinking patients.

Autor: Pérot, Philippe¹ (AUTHOR), Falguieres, Michaël² (AUTHOR), Arowas, Laurence² (AUTHOR), Laude, Hélène² (AUTHOR), Foy, Jean-Philippe³ (AUTHOR), Goudot, Patrick⁴ (AUTHOR), Corre-Catelin, Nicole⁵ (AUTHOR), Ungeheuer, Marie-Noëlle⁵ (AUTHOR), Caro, Valérie⁶ (AUTHOR), Heard, Isabelle² (AUTHOR), Eloit, Marc^1,7 (AUTHOR), Gessain, Antoine⁸ (AUTHOR), Bertolus, Chloé^4,9 (AUTHOR) chloe.bertolus@aphp.fr, Berthet, Nicolas^6,8 (AUTHOR) chloe.bertolus@aphp.fr

Publikováno v: PLoS ONE. 4/29/2020, Vol. 15 Issue 4, p1-16. 16p.